Keywords: hybridon, starts, campto/antisense, trial, antisense, therapeutic, specialist

Hybridon starts Campto/antisense trial

Article | 11 March 2002

Print This

US antisense therapeutic specialist Hybridon has initiated a Phase I/IIclinical trial to study the combination of its GEM 231 drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in